Neogen Total Long Term Liabilities 2010-2024 | NEOG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Neogen total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Neogen total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$221.8B
Boston Scientific (BSX)	$151.4B
Stryker (SYK)	$149.1B
EssilorLuxottica (ESLOY)	$125.1B
Medtronic (MDT)	$117.2B
Lonza Group Ag (LZAGY)	$46B
Haleon (HLN)	$43.1B
GE HealthCare Technologies (GEHC)	$40.1B
ResMed (RMD)	$37.1B
Terumo (TRUMY)	$28.9B
Koninklijke Philips (PHG)	$25.6B
Zimmer Biomet Holdings (ZBH)	$22.1B
Insulet (PODD)	$19.4B
Baxter (BAX)	$16.7B
Smith & Nephew SNATS (SNN)	$11.1B
BellRing Brands (BRBR)	$10.1B
Sunny Optical Technology (SNPTF)	$10B
Bio-Rad Laboratories (BIO)	$10B
Demant (WILYY)	$8.7B
Lantheus Holdings (LNTH)	$6.4B
ICU Medical (ICUI)	$4.1B
Prestige Consumer Healthcare (PBH)	$3.9B
Envista Holdings (NVST)	$3.7B
Haemonetics (HAE)	$3.4B
Perrigo (PRGO)	$3.4B
GN Store Nord (GNNDY)	$3B
Shandong Weigao Medical Polymer (SHWGF)	$3B
QuidelOrtho (QDEL)	$2.9B
LeMaitre Vascular (LMAT)	$2.2B
AtriCure (ATRC)	$2.1B